Gapping up
In reaction to strong earnings/guidance:
- NOG +14.3%, CRNT +5.9%, TA +5.5%, ARQL +3.8%, ILMN +1.7%, BWXT +1.1%, BRK.B +0.4%
M&A news:
- MDLZ +0.5% (to acquire Tate's Bake Shop for approximately $500 mln)
Other news:
- NVAX +4.3% (reaches enrollment milestone of ~4,600 participants in Prepare Phase 3 trial of RSV F Vaccine)
- WFC +1.5% (reaches agreement in principle to resolve consolidated securities fraud class action)
- VRX +1.3% (FDA has approved PLENVU)
Analyst comments:
- BILI +2.1% (initiated with a Overweight at JP Morgan)
- CVRR +2% (upgraded to Buy from Neutral at Goldman)
- ILMN +1.7% (upgraded to Overweight from Equal Weight at Barclays)
- DE +1.6% (upgraded to Outperform from In-line at Evercore ISI)
- CLDR +1.5% (initiated with a Buy at Craig Hallum)
- MCD +1.2% (added to Conviction Buy List at Goldman)
- AZO +0.8% (added to Conviction Buy List at Goldman)
- AMZN +0.5% (initiated with a Outperform at Telsey Advisory Group)
![]()